Generation Bio Co.

Informe acción NasdaqGS:GBIO

Capitalización de mercado: US$36.0m

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Salud financiera de hoja de balance de Generation Bio

Salud financiera controles de criterios 4/6

Generation Bio tiene un patrimonio de los accionistas total de $50.6M y una deuda total de $0.0, lo que sitúa su ratio deuda-patrimonio en 0%. Sus activos y pasivos totales son $121.9M y $71.3M respectivamente.

Información clave

0%

Ratio deuda-patrimonio

US$0

Deuda

Ratio de cobertura de interesesn/a
EfectivoUS$89.62m
PatrimonioUS$50.56m
Total pasivoUS$71.34m
Activos totalesUS$121.90m

Actualizaciones recientes sobre salud financiera

Artículo de análisis Nov 14

Companies Like Generation Bio (NASDAQ:GBIO) Could Be Quite Risky

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Artículo de análisis May 01

We Think Generation Bio (NASDAQ:GBIO) Can Afford To Drive Business Growth

Just because a business does not make any money, does not mean that the stock will go down. For example, although...
Artículo de análisis Dec 07

We Think Generation Bio (NASDAQ:GBIO) Can Afford To Drive Business Growth

Just because a business does not make any money, does not mean that the stock will go down. For example, although...
Artículo de análisis Jul 11

Companies Like Generation Bio (NASDAQ:GBIO) Can Afford To Invest In Growth

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...
Artículo de análisis Mar 11

We're Hopeful That Generation Bio (NASDAQ:GBIO) Will Use Its Cash Wisely

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...

Recent updates

Artículo de análisis Nov 14

Companies Like Generation Bio (NASDAQ:GBIO) Could Be Quite Risky

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Artículo de análisis Jul 14

There Is A Reason Generation Bio Co.'s (NASDAQ:GBIO) Price Is Undemanding

With a price-to-sales (or "P/S") ratio of 1.1x Generation Bio Co. ( NASDAQ:GBIO ) may be sending very bullish signals...
Artículo de análisis Mar 16

Generation Bio Co. (NASDAQ:GBIO) Not Doing Enough For Some Investors As Its Shares Slump 29%

Unfortunately for some shareholders, the Generation Bio Co. ( NASDAQ:GBIO ) share price has dived 29% in the last...
Artículo de análisis May 01

We Think Generation Bio (NASDAQ:GBIO) Can Afford To Drive Business Growth

Just because a business does not make any money, does not mean that the stock will go down. For example, although...
Artículo de análisis Dec 07

We Think Generation Bio (NASDAQ:GBIO) Can Afford To Drive Business Growth

Just because a business does not make any money, does not mean that the stock will go down. For example, although...
Artículo de análisis Jul 11

Companies Like Generation Bio (NASDAQ:GBIO) Can Afford To Invest In Growth

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...
Artículo de análisis Mar 11

We're Hopeful That Generation Bio (NASDAQ:GBIO) Will Use Its Cash Wisely

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...
Artículo de análisis Nov 19

Generation Bio (NASDAQ:GBIO) Is In A Good Position To Deliver On Growth Plans

We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
Artículo de análisis Aug 05

We're Hopeful That Generation Bio (NASDAQ:GBIO) Will Use Its Cash Wisely

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...
Seeking Alpha Aug 04

Generation Bio GAAP EPS of -$0.66 misses by $0.04

Generation Bio press release (NASDAQ:GBIO): Q2 GAAP EPS of -$0.66 misses by $0.04. The company believes that its cash position of $312.2M will fund its operating plan into 2025. “We are advancing our leading non-viral genetic medicine platform to unlock the potential of durable, redosable non-viral DNA therapeutics, and we have made significant progress in establishing the proprietary technologies necessary to realize our vision,” said Geoff McDonough, M.D., president and chief executive officer of Generation Bio. “This quarter, process development and scaling of rapid enzymatic synthesis (RES) for production of our closed-ended DNA (ceDNA) construct has allowed us to pursue a more flexible and capital efficient manufacturing strategy. In the remainder of the year, we plan to continue to develop our unique cell-targeted lipid nanoparticle (ctLNP) system for systemic delivery to hepatocytes, as well as for other therapeutic areas such as the retina and vaccines.”
Artículo de análisis Apr 20

Companies Like Generation Bio (NASDAQ:GBIO) Are In A Position To Invest In Growth

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...
Seeking Alpha Dec 30

Generation Bio: High-Risk, Medium-To-Low-Reward

Generation Bio is a preclinical-stage gene therapy company aiming to use non-viral delivery system to deliver DNA in vivo. The non-viral delivery system of choice is lipid nanoparticle, similar delivery vehicle the mRNA COVID vaccines are using. The big issue is, LNP will not help with nuclear translocation which is needed for DNA gene therapy to have decent efficacy. The recent preclinical update on their Hemophilia A program confirms the low efficacy issue of LNP-DNA, and therefore the stock is not a buy.
Artículo de análisis Nov 11

We Think Generation Bio (NASDAQ:GBIO) Can Afford To Drive Business Growth

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...
Artículo de análisis Jul 28

We Think Generation Bio (NASDAQ:GBIO) Can Afford To Drive Business Growth

We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
Artículo de análisis Mar 08

Here's Why We're Not Too Worried About Generation Bio's (NASDAQ:GBIO) Cash Burn Situation

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Artículo de análisis Jan 14

Trade Alert: The Independent Director Of Generation Bio Co. (NASDAQ:GBIO), Charles Rowland, Has Just Spent US$500k Buying 25% More Shares

Potential Generation Bio Co. ( NASDAQ:GBIO ) shareholders may wish to note that the Independent Director, Charles...
Artículo de análisis Dec 27

Should You Take Comfort From Insider Transactions At Generation Bio Co. (NASDAQ:GBIO)?

We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. The...

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo ($93.5M) de GBIO superan a sus pasivos a corto plazo ($21.0M).

Pasivo a largo plazo: Los activos a corto plazo de GBIO ($93.5M) superan a sus pasivos a largo plazo ($50.3M).


Historial y análisis de deuda-patrimonio

Nivel de deuda: GBIO está libre de deudas.

Reducción de la deuda: GBIO no ha tenido ninguna deuda en los últimos 5 años.


Hoja de balance


Análisis de cash runway

En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.

Cash runway estable: GBIO tiene menos de un año de cash runway basado en su flujo de caja libre actual.

Pronóstico de cash runway: GBIO tiene menos de un año de cash runway si el flujo de caja libre sigue reduciéndose a tasas históricas de 4.1% cada año


Descubre empresas con salud financiera

Análisis de la empresa y estado de los datos financieros

DatosÚltima actualización (huso horario UTC)
Análisis de la empresa2026/02/10 00:04
Precio de las acciones al final del día2026/02/06 00:00
Beneficios2025/09/30
Ingresos anuales2024/12/31

Fuentes de datos

Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.

PaqueteDatosMarco temporalEjemplo Fuente EE.UU. *
Finanzas de la empresa10 años
  • Cuenta de resultados
  • Estado de tesorería
  • Balance
Estimaciones del consenso de analistas+3 años
  • Previsiones financieras
  • Objetivos de precios de los analistas
Precios de mercado30 años
  • Precios de las acciones
  • Dividendos, escisiones y acciones
Propiedad10 años
  • Accionistas principales
  • Información privilegiada
Gestión10 años
  • Equipo directivo
  • Consejo de Administración
Principales avances10 años
  • Anuncios de empresas

* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.

A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.

Modelo de análisis y copo de nieve

Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también contamos con guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.

Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.

Métricas industriales y sectoriales

Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.

Fuentes analistas

Generation Bio Co. está cubierta por 3 analistas. 3 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.

AnalistaInstitución
Silvan TuerkcanCitizens JMP Securities, LLC
Brendan SmithTD Cowen
Raju PrasadWilliam Blair & Company L.L.C.